Recurrent Small Cell Lung Carcinoma
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Nektar TherapeuticsSAN FRANCISCO, CA
1 program1
Laboratory Biomarker AnalysisPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Karyopharm TherapeuticsSelinexor
Nektar TherapeuticsLaboratory Biomarker Analysis
Clinical Trials (2)
Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer
Start: May 2015Est. completion: Mar 2016
Phase 2Terminated
Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer
Start: Aug 2013Est. completion: Feb 2020
Phase 2Completed
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
23m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
23m ago
Office Administrator
SystImmune
24m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
34m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
37m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
37m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space